Angiotensin II Type 1 Receptor Blockers: all 909 studies that test it
Page 5 of 10. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Phase I Drug-drug Interaction of Omega-3 and AtorvastatinStatus unknownNCT03438955Phase 1
- Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240CompletedNCT03435939Early Phase 1
- The Effect of Losartan on Emotional Processing in Healthy VolunteersCompletedNCT03434054Not applicable
- Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive WomenStatus unknownNCT03432468Not applicable
- Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart FailureWithdrawnNCT03415906Phase 2
- Losartan and Emotion ProcessingStatus unknownNCT03396523Not applicable
- Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1Status unknownNCT03357653Phase 3
- AT1R Blockade and Periodic Breathing During Sleep in HypoxiaCompletedNCT03335904Phase 4
- Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II StudyWithdrawnNCT03315832Phase 2/3
- Sacubitril-valsartan Versus Usual Anti-hypertensives in LVADWithdrawnNCT03279861Phase 4
- A Study on Molecular Genetics of Drug Responsiveness in Essential HypertensionCompletedNCT03276598Phase 4
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCompletedNCT03247140Phase 1
- Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and DyslipidemiaCompletedNCT03210532Phase 3
- Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVHCompletedNCT03180593Phase 4
- Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and IrbesartanCompletedNCT03147677Phase 4
- Matão Controlling Hypertension (MatCH Study): Rationale and DesignStatus unknownNCT03147092Early Phase 1
- Comparing ARNI With ACE Inhibitor on Endothelial FunctionWithdrawnNCT03119623Phase 4
- Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2WithdrawnNCT03005184Phase 2
- Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose TissueStatus unknownNCT02996916Phase 4
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedNCT02988362Phase 1
- Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With HypertensionCompletedNCT02973035Phase 4
- A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic SyndromeTerminatedNCT02968160Phase 4
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedNCT02944734Phase 2
- Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCompletedNCT02933658Phase 1
- Strategies to Promote Cessation in Smokers Who Are Not Ready To QuitCompletedNCT02905656Not applicable
- Expression and Function of the Renin-Angiotensin System in the EsophagusCompletedNCT02879721Early Phase 1
- Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCompletedNCT02842359Phase 4
- The DDI Study of SP2086 and ValsartanStatus unknownNCT02817217Phase 1
- The Drug-drug Interaction of SP2086 and ValsartanCompletedNCT02815657Phase 1
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - BCompletedNCT02811731Phase 1
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - ACompletedNCT02801526Phase 1
- Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart FailureTerminatedNCT02787798Phase 4
- The Precision Hypertension Care StudyCompletedNCT02774460Phase 4
- Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein StenosisSuspendedNCT02769130Phase 1/2
- N-of-1 Trials for Blood Pressure Medications in AdultsCompletedNCT02744456Early Phase 1
- Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension PatientsCompletedNCT02738632Phase 3
- Clinical Trial to Compare the Pharmacokinetics of DP-R208CompletedNCT02707224Phase 1
- Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialCompletedNCT02699645Phase 3
- Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular EdemaCompletedNCT02663141Phase 2
- Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.WithdrawnNCT02662894Phase 3
- Chronopharmacology of Valsartan in Normotensive SubjectsCompletedNCT02631031Phase 1
- Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male SugjectsStatus unknownNCT02609711Phase 1
- Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)CompletedNCT02597361Phase 3
- To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male VolunteersCompletedNCT02579356Phase 1
- Physiologic Interactions Between the Adrenal- and the Parathyroid GlandsCompletedNCT02572960Phase 4
- Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension ControlWithdrawnNCT02521246Phase 3
- Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02521233Phase 3
- A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)CompletedNCT02519010Phase 1
- Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mgCompletedNCT02518451Not applicable
- The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseStatus unknownNCT02516826Phase 2
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02493322Phase 3
- Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnNCT02483936Phase 3
- The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/AmlodipineCompletedNCT02387619Phase 1
- Effectiveness of Avapro in Obese Normotensive/Hypertensive African AmericansStatus unknownNCT02386293Phase 2
- Multiple Treatments for Ebola Virus Disease (EVD)Status unknownNCT02380625Phase 1/2
- Lowering Blood Pressure in Primary Care in ViennaCompletedNCT02377661Phase 4
- Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)TerminatedNCT02373462Phase 4
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedNCT02368652Phase 3
- Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)Status unknownNCT02360956Phase 4
- A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and ValsartanCompletedNCT02343250Phase 1
- Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney DiseaseStatus unknownNCT02299310Phase 4
- Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive PatientsCompletedNCT02294539Phase 4
- Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male VolunteersCompletedNCT02263989Phase 1
- Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers IICompletedNCT02262858Phase 1
- Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male SubjectsCompletedNCT02262793Phase 1
- Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female SubjectsCompletedNCT02262650Phase 1
- Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male VolunteersCompletedNCT02262585Phase 1
- Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male VolunteersCompletedNCT02262559Phase 1
- Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male VolunteersCompletedNCT02261129Phase 1
- Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy VolunteersCompletedNCT02261116Phase 4
- Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNCT02259829Phase 1
- Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy VolunteersCompletedNCT02259816Phase 1
- Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake PopulationCompletedNCT02255253Not applicable
- Relative Bioavailability Study of Candesartan Cilexetil Under Fasting ConditionsCompletedNCT02254447Phase 1
- Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate HypertensionTerminatedNCT02242812Phase 4
- Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With HypertensionCompletedNCT02242344Phase 2
- Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure MonitoringCompletedNCT02242318Phase 4
- Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure PatientsWithdrawnNCT02238457Phase 4
- The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCompletedNCT02233218Phase 1
- Efficacy and Safety of Losartan in Children With Ig A NephropathyCompletedNCT02232776Phase 3
- Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular ProteinuriaCompletedNCT02232763Phase 3
- Efficacy and Safety of Abelmoschus Manihot for IgA NephropathyStatus unknownNCT02231125Phase 4
- Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male SubjectsCompletedNCT02218684Phase 1
- Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female VolunteersCompletedNCT02215005Phase 1
- Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female VolunteersCompletedNCT02214992Phase 1
- Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female VolunteersCompletedNCT02214979Phase 1
- Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT02213224Phase 4
- the Pharmacokinetic Profiles of Losartan With DW1029MCompletedNCT02212769Phase 1
- Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT02206659Phase 3
- A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionStatus unknownNCT02206165Phase 2
- Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy SubjectsCompletedNCT02203500Phase 1
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200653Phase 4
- A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200640Phase 4
- Bioequivalence Study of Valsartan 320mg Tablets Under Fed ConditionsCompletedNCT02197494Not applicable
- Bioequivalence Study of Valsartan 320mg Tablets Under Fasting ConditionsCompletedNCT02197442Not applicable
- Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNCT02193308Phase 1
- Residual Renal Function Preservation in Peritoneal Dialysis PatientsStatus unknownNCT02190318Not applicable
- Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy SubjectsCompletedNCT02187536Phase 1
- Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy SubjectsCompletedNCT02187523Phase 1
- BIBR 277 Capsules in Hypertensive Patients With NephropathyCompletedNCT02187484Phase 2